Cohen & Steers’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Hold
6,000
﹤0.01% 317
2025
Q4
$324K Hold
6,000
﹤0.01% 322
2025
Q3
$271K Hold
6,000
﹤0.01% 332
2025
Q2
$278K Buy
+6,000
New +$295K ﹤0.01% 329
2018
Q2
Sell
-277,521
Closed -$17.6M 443
2018
Q1
$17.6M Sell
277,521
-32,176
-10% -$2.07M 0.05% 122
2017
Q4
$19M Buy
309,697
+20,323
+7% +$1.27M 0.05% 129
2017
Q3
$18.4M Sell
289,374
-134,459
-32% -$7.85M 0.05% 126
2017
Q2
$23.6M Sell
423,833
-83
-0% -$4.52K 0.06% 130
2017
Q1
$23.1M Buy
423,916
+142,820
+51% +$7.83M 0.06% 131
2016
Q4
$16.4M Buy
281,096
+127,400
+83% +$6.96M 0.05% 144
2016
Q3
$8.29M Buy
+153,696
New +$9.87M 0.02% 206
2013
Q3
Sell
-3,300
Closed -$147K 415
2013
Q2
$147K Buy
+3,300
New +$143K ﹤0.01% 371

Other funds holding BMY

Cohen & Steers's BMY Position: Q1 2026 in Review

Cohen & Steers held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,000 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Cohen & Steers first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $23.6M in Q2 2017. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cohen & Steers held 6,000 shares of Bristol-Myers Squibb worth $364K as of Q1 2026.
  • Cohen & Steers left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Cohen & Steers's portfolio in Q1 2026, its #317 holding.
  • Cohen & Steers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
  • Cohen & Steers's Bristol-Myers Squibb position peaked at $23.6M in Q2 2017.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cohen & Steers's 13F filing for Q1 2026, filed 15 May 2026.